Abstract: The invention relates to the use of valnoctamide (VCD) for the treatment of bipolar disorder and in particular for the treatment of the manic phase of the bipolar disorder.
Type:
Grant
Filed:
June 15, 2006
Date of Patent:
March 19, 2013
Assignee:
Yissum Research Developmemt Company of the Hebrew University of Jerusalem